Connor, Clark & Lunn Investment Management (CC&L)’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
Other funds holding SEM
GCL
Connor, Clark & Lunn Investment Management (CC&L)'s SEM Position: Q1 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Select Medical (SEM) in Q1 2026, closing a stake of 93,889 shares — an estimated $1.39M sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SEM in Q2 2013 and held it in 22 quarters. The position peaked at $3.67M in Q3 2014. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 93,889 Select Medical shares in Q1 2026, an estimated $1.39M.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Select Medical in Q2 2013 and held it in 22 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Select Medical position peaked at $3.67M in Q3 2014.
- 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.